| Pharmaceutical active ingredients: |
| Isoetharine |
| Available forms, composition and doses of Neoisuprel: |
| N / A |
| Neoisuprel medical category: |
| Human:Beta2-adrenergic receptors agonists |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| R03AC07 - IsoetarineR03CC06 - Isoetarine |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Unidentified Pharmaceutical Company |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Fazol | Isoconazole Nitrate Micronized | CS Dermatologie |
| Fazol G | Isoconazole Nitrate Micronized | CS Dermatologie; Sinclair Pharmaceuticals |
| Dey-Lute Isoetharine | Isoetharine | Unidentified Pharmaceutical Company |
| Dilabron | Isoetharine | Unidentified Pharmaceutical Company |
| Etyprenaline | Isoetharine | Unidentified Pharmaceutical Company |
| Arm-A Med Isoetharine | Isoetharine Hydrochloride | Unidentified Pharmaceutical Company |
| Asthmalitan | Isoetharine Hydrochloride | 3M |
| Beta-2 | Isoetharine Hydrochloride | Nephron Pharmaceuticals |
| Bronkosol | Isoetharine Hydrochloride | Sanofi-Aventis |
| Isoetharine | Isoetharine Hydrochloride | AstraZeneca |